/IAGX

IAGX Stock - Imagenetix, Inc.

Q: What is the analyst price target for IAGX?

Analyst price target information is not currently available for IAGX.

Q: What is IAGX's market cap?

Market capitalization information is not currently available for IAGX.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for IAGX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2007

FY2008

FY2009

FY2010

FY2014

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-406.06

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2014	FY2010	FY2009	FY2008	FY2007
Revenue	$824,499	$7.13M	$6.60M	$7.46M	$5.57M
Gross Profit	$342,939	$3.07M	$2.86M	$3.46M	$2.23M
Gross Margin	41.6%	43.0%	43.4%	46.3%	40.0%
Operating Income	$14,345	$-3,306,756	$-2,278,189	$-919,201	$-2,229,757
Net Income	$-21,712	$-2,167,594	$-697,104	$429,956	$-1,776,642
Net Margin	-2.6%	-30.4%	-10.6%	5.8%	-31.9%
EPS	$-0.00	$-0.19	$-0.06	$0.04	$-0.16

Company Overview

Imagenetix, Inc. develops, formulates, and markets proprietary and natural based nutritional supplements, and over-the-counter topical creams and skin care products. Its primary product is Celadrin, a product formulation for joint health. The company also licenses its intellectual property to third parties. Imagenetix, Inc. markets its products through various channels of distribution, including direct and mass marketing companies, nutritional newsletters, and medical and nutritional oriented professionals; medical newsletters; and direct response radio and television. The company was founded in 1996 and is based in San Diego, California.

Visit Website

Frequently Asked Questions about IAGX

What is IAGX's current stock price?

Imagenetix, Inc. (IAGX) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for IAGX?

No analyst price targets are currently available for this stock.

What sector is Imagenetix, Inc. in?

Imagenetix, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is IAGX's market cap?

Imagenetix, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does IAGX pay dividends?

No, Imagenetix, Inc. does not currently pay a dividend to shareholders.